Atlas Trials

Effects of EPA Supplementation on Patients With Unresectable Hepatocellular Carcinoma.

Clinical trial NCT07664007 · COMPLETED

Trial details

NCT number
NCT07664007
Sponsor
Instituto de Investigación Sanitaria Aragón
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2019-03-04
Primary completion
2023-09-17
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.